NCT06620614View on ClinicalTrials.gov

A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group.

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2023

Conditions
Prostatic Hyperplasia, Benign
Interventions
COMBINATION_PRODUCT

0.5% Heavy Bupivacaine

There are two groups.

Trial Locations (1)

+977

National Academy of Medical Sciences, Bir Hospital, Kathmandu

All Listed Sponsors
lead

National Academy of Medical Sciences, Nepal

OTHER_GOV